News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Earnhardt Lisa D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2023 |
4
| Earnhardt Lisa D (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 7,631 shares
@ $99.77, valued at
$761.3k
Sold 943 shares
@ $100.7, valued at
$95k
|
|
| 02/22/2023 |
4
| Earnhardt Lisa D (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 15,855 shares
@ $0
Granted 62,527 options to buy
@ $106.24, valued at
$6.6M
|
|
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Earnhardt Lisa D (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 17,247 shares
@ $0
Granted 80,380 options to buy
@ $117.58, valued at
$9.5M
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Earnhardt Lisa D (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 2,855 shares
@ $90.27, valued at
$257.7k
Sold 872 shares
@ $90.844, valued at
$79.2k
|
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2019 |
4
| Earnhardt Lisa D (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Disposed/sold 44,625 options to buy
@ $33.95, valued at
$1.5M
Granted 44,625 options to buy
@ $33.95, valued at
$1.5M
Disposed/sold 19,688 options to buy
@ $28.58, valued at
$562.7k
Granted 19,688 options to buy
@ $28.58, valued at
$562.7k
Disposed/sold 150,000 options to buy
@ $21.06, valued at
$3.2M
Granted 150,000 options to buy
@ $21.06, valued at
$3.2M
Disposed/sold 196,875 options to buy
@ $18.9, valued at
$3.7M
Granted 196,875 options to buy
@ $18.9, valued at
$3.7M
Disposed/sold 45,500 options to buy
@ $13.05, valued at
$593.8k
Granted 45,500 options to buy
@ $13.05, valued at
$593.8k
Disposed/sold 48,333 options to buy
@ $1.2, valued at
$58k
|
|
| 06/12/2019 |
4
| Earnhardt Lisa D (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 17,431 shares
@ $0
Granted 39,515 shares
@ $0
Granted 91,367 options to buy
@ $80.98, valued at
$7.4M
|
|
| 06/12/2019 |
3
| Earnhardt Lisa D (Executive Vice President) has filed a Form 3 on ABBOTT LABORATORIES |
| 05/17/2019 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 9,500 shares
@ $25.5897, valued at
$243.1k
Exercised 9,500 options to buy
@ $13.05, valued at
$124k
|
|
| 04/17/2019 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 29,588 shares
@ $28.4319, valued at
$841.2k
Exercised 7,500 options to buy
@ $13.05, valued at
$97.9k
Exercised 6,016 options to buy
@ $1.2, valued at
$7.2k
|
|
| 01/18/2019 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Granted 33,800 shares
@ $0
Granted 157,500 options to buy
@ $28.58, valued at
$4.5M
|
|
| 01/03/2019 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Paid exercise price by delivering 10,428 shares
@ $26.5675, valued at
$277k
|
|
| 12/26/2018 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Exercised 35,000 options to buy
@ $1.2, valued at
$42k
|
|
| 12/19/2018 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 20,000 shares
@ $29.7252, valued at
$594.5k
Exercised 5,000 options to buy
@ $13.05, valued at
$65.3k
|
|
| 10/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2018 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 20,000 shares
@ $29.1431, valued at
$582.9k
Exercised 5,000 options to buy
@ $13.05, valued at
$65.3k
|
|
| 08/17/2018 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 20,000 shares
@ $26.5097, valued at
$530.2k
Exercised 5,000 options to buy
@ $13.05, valued at
$65.3k
|
|
| 07/18/2018 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 20,000 shares
@ $33.0843, valued at
$661.7k
Exercised 5,000 options to buy
@ $13.05, valued at
$65.3k
|
|
| 06/19/2018 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 20,000 shares
@ $36.7855, valued at
$735.7k
Exercised 5,000 options to buy
@ $13.05, valued at
$65.3k
|
|
| 05/23/2018 |
4
| Earnhardt Lisa D (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 3,785 shares
@ $0 |
|
| 05/17/2018 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 15,000 shares
@ $39.2163, valued at
$588.2k
Exercised 15,000 options to buy
@ $13.05, valued at
$195.8k
|
|
| 04/17/2018 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 15,000 shares
@ $39.5945, valued at
$593.9k
Exercised 15,000 options to buy
@ $13.05, valued at
$195.8k
|
|
| 03/16/2018 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 15,000 shares
@ $38.3194, valued at
$574.8k
Exercised 15,000 options to buy
@ $13.05, valued at
$195.8k
|
|
| 02/16/2018 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 15,000 shares
@ $36.3959, valued at
$545.9k
Exercised 15,000 options to buy
@ $13.05, valued at
$195.8k
|
|
| 01/19/2018 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Granted 25,500 shares
@ $0
Sold 11,166 shares
@ $33.4672, valued at
$373.7k
Granted 119,000 options to buy
@ $33.95, valued at
$4M
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2017 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 10,685 shares
@ $31.8682, valued at
$340.5k
Exercised 2,000 options to buy
@ $1.2, valued at
$2.4k
|
|
| 11/17/2017 |
4
| Earnhardt Lisa D (President and CEO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 20,000 shares
@ $27.881, valued at
$557.6k
Exercised 10,000 options to buy
@ $1.2, valued at
$12k
|
|
| 10/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|